About
Puretech Health Plc (LSE:PRTC) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
PRTC's Seaport Adds Neuropsychiatry Veteran to BOD
Apr 22 2026
PRTC's Gallop: Positive Ph1 Topline MDS & AML Data
Apr 13 2026
PRTC's Seaport Files for Proposed Nasdaq IPO
Apr 2 2026
PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
Apr 2 2026
PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
Financials
Revenue
GBX6.39 M
Market Cap
GBX275.06 M
P/E Ratio
8.69
EPS
0.13
Translate